Next Article in Journal
Association between Stress and the HPA Axis in the Atopic Dermatitis
Next Article in Special Issue
View Point: Semaphorin-3E: An Emerging Modulator of Natural Killer Cell Functions?
Previous Article in Journal
Neuro-Coagulopathy: Blood Coagulation Factors in Central Nervous System Diseases
Previous Article in Special Issue
Natural Killer Cells: Angels and Devils for Immunotherapy
Review

Control of NK Cell Activation by Immune Checkpoint Molecules

1
Laboratoire d’Immunologie, Hôpital Henri Mondor, Assistance Publique–Hôpitaux de Paris, 94000 Créteil, France
2
Centre de Recherches sur l’Inflammation, Institut National de Recherche Médicale (INSERM) UMR1149, Université Paris Diderot, 75013 Paris, France
3
Laboratoire d’Immunologie, Hôpital Saint-Louis, Assistance Publique–Hôpitaux de Paris, 75010 Paris, France
*
Author to whom correspondence should be addressed.
Int. J. Mol. Sci. 2017, 18(10), 2129; https://doi.org/10.3390/ijms18102129
Received: 19 September 2017 / Revised: 4 October 2017 / Accepted: 9 October 2017 / Published: 12 October 2017
(This article belongs to the Special Issue Natural Killer (NK) Cells)
The development of cancer and chronic infections is facilitated by many subversion mechanisms, among which enhanced expression of immune checkpoints molecules, such as programmed death-1 (PD-1) and cytotoxic T lymphocyte-associated antigen 4 (CTLA-4), on exhausted T cells. Recently, immune checkpoint inhibitors have shown remarkable efficiency in the treatment of a number of cancers. However, expression of immune checkpoints on natural killer (NK) cells and its functional consequences on NK cell effector functions are much less explored. In this review, we focus on the current knowledge on expression of various immune checkpoints in NK cells, how it can alter NK cell-mediated cytotoxicity and cytokine production. Dissecting the role of these inhibitory mechanisms in NK cells is critical for the full understanding of the mode of action of immunotherapies using checkpoint inhibitors in the treatment of cancers and chronic infections. View Full-Text
Keywords: NK cells; immune checkpoint molecules; cancer immunotherapy NK cells; immune checkpoint molecules; cancer immunotherapy
MDPI and ACS Style

Beldi-Ferchiou, A.; Caillat-Zucman, S. Control of NK Cell Activation by Immune Checkpoint Molecules. Int. J. Mol. Sci. 2017, 18, 2129. https://doi.org/10.3390/ijms18102129

AMA Style

Beldi-Ferchiou A, Caillat-Zucman S. Control of NK Cell Activation by Immune Checkpoint Molecules. International Journal of Molecular Sciences. 2017; 18(10):2129. https://doi.org/10.3390/ijms18102129

Chicago/Turabian Style

Beldi-Ferchiou, Asma; Caillat-Zucman, Sophie. 2017. "Control of NK Cell Activation by Immune Checkpoint Molecules" Int. J. Mol. Sci. 18, no. 10: 2129. https://doi.org/10.3390/ijms18102129

Find Other Styles
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.

Article Access Map by Country/Region

1
Search more from Scilit
 
Search
Back to TopTop